Czechia

This document presents the Secretariat of the Government Council for Drug Policy Coordination, Czechia's (2022 Summary report on the implementation of Czechia's Addiction Action Plan 2019–22.

This document presents the Government Council for Drug Policy Coordination, Czechia’s Addiction Policy Action Plan 2023–25.

Prevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population under study. Interview surveys are...

Information on the number of people entering treatment for a drug problem provides insight into general trends in problem drug use and also offers a perspective on the organisation and uptake of...

Reports of offences against national drug legislation (use, possession, trafficking, etc.) reflect differences in law but also the different ways in which the law is enforced and applied, and the priorities and...

Health and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-, pharmacy- and non pharmacy-based programmes and...

National routine information on drug use and patterns of use amongst prisoners is rare. Most of the data available in the EU come from ad-hoc studies amongst prisoners, carried out at local...

The EMCDDA collects data on the prevalence and incidence of infectious diseases — primarily HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) — among people who inject drugs (PWID). Data...

Street prices of cannabis, heroin, cocaine and amphetamine are provided in euros per gram, of LSD in euros per unit/dose, and of ecstasy in euros per tablet. Data on prices come from...

Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with national experts, has defined an epidemiological...